Efficacy of donepezil on secondary end points in a randomized, double-blind placebo-controlled study in severe Alzheimer's disease

被引：0
|
作者：
Eriksson, S
Winblad, B
Kilander, L
Batsman, S
Jansson-Blixt, C
Wetterholm, AL
Haglund, A
Minthon, L
机构：
[1] Umea Univ, Umea, Sweden
[2] Karolinska Inst, Stockholm, Sweden
[3] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden
[4] Kalix Vardcent, Dept Primary Care, Kalix, Sweden
[5] Pfizer Biostat, Taby, Sweden
[6] Pfizer Neurosci, Taby, Sweden
[7] Univ Hosp MAS, Neuropsychiat Clin, Malmo, Sweden
来源：
INTERNATIONAL PSYCHOGERIATRICS | 2005年 / 17卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [41] A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease
    Petracca, GM
    Chemerinski, E
    Starkstein, SE
    INTERNATIONAL PSYCHOGERIATRICS, 2001, 13 (02) : 233 - 240
  • [42] A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease
    Petracca, G
    Teson, A
    Chemerinski, E
    Leiguarda, R
    Starkstein, SE
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1996, 8 (03) : 270 - 275
  • [43] Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study (vol 367, pg 1057, 2006)
    Winblad, B.
    Kilander, L.
    Eriksson, S.
    LANCET, 2006, 368 (9548): : 1650 - 1650
  • [44] Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study (vol 367, pg 1057, 2006)
    Winblad, B
    Kilander, L
    Eriksson, S
    LANCET, 2006, 367 (9527): : 1980 - 1980
  • [45] A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy
    Hamberger, Marla J.
    Palmese, Christina A.
    Scarmeas, Nikolaos
    Weintraub, David
    Choi, Hyunmi
    Hirsch, Lawrence J.
    EPILEPSIA, 2007, 48 (07) : 1283 - 1291
  • [46] A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Subbiah, P
    Whalen, E
    NEUROLOGY, 2001, 57 (04) : 613 - 620
  • [47] Alefacept for Severe Alopecia Areata A Randomized, Double-blind, Placebo-Controlled Study
    Strober, Bruce E.
    Menon, Kavita
    McMichael, Amy
    Hordinsky, Maria
    Krueger, Gerald
    Panko, Jackie
    Siu, Kimberly
    Lustgarten, Jonathan L.
    Ross, Elizabeth K.
    Shapiro, Jerry
    ARCHIVES OF DERMATOLOGY, 2009, 145 (11) : 1262 - 1266
  • [48] Velnacrine for the treatment of Alzheimer's disease: A double-blind, placebo-controlled trial
    Zemlan, FP
    Folks, DG
    Goldstein, BJ
    Gottlieb, G
    Holub, RF
    Linden, RD
    Margolin, RA
    Richter, RW
    Speakman, WF
    Strub, RL
    JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (8-9) : 1105 - 1116
  • [49] A double-blind, placebo-controlled trial of diclofenac misoprostol in Alzheimer's disease
    Scharf, S
    Mander, A
    Ugoni, A
    Vajda, F
    Christophidis, N
    NEUROLOGY, 1999, 53 (01) : 197 - 201
  • [50] Donepezil improves cognition and global function in Alzheimer disease - A 15-week, double-blind, placebo-controlled study
    Rogers, SL
    Doody, RS
    Mohs, RC
    Friedhoff, LT
    ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (09) : 1021 - 1031
12345